Sampre Nutritions Intrinsic Value
Sampre Nutritions intrinsic value. Sampre Nutritions (SAMPRE) median intrinsic value is ₹16.38 from 8 valuation models (range ₹5–₹18), vs current price ₹6.01 — +172.5% upside (Trading Below Calculated Value), margin of safety 63.3%. Read Sampre Nutritions dividend payments for the complete payout history and dividend yield track record.
SAMPRE Valuation Methods Summary — DCF, Graham Number & P/E
Sampre Nutritions intrinsic value across 8 models vs current price ₹6.01 — upside/downside and value range per method. Compare with SAMPRE fair value to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹18.03 | ₹14.42 - ₹21.64 | +200.0% | EPS: ₹2.56, Sector P/E: 12x |
| Book Value Method | asset | ₹15.02 | ₹13.52 - ₹16.52 | +149.9% | Book Value/Share: ₹22.29, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹10.67 | ₹9.60 - ₹11.74 | +77.5% | Revenue/Share: ₹13.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹5.00 | ₹4.50 - ₹5.50 | -16.8% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹11.32 | ₹9.06 - ₹13.58 | +88.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹16.38 | ₹14.74 - ₹18.02 | +172.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹18.03 | ₹16.23 - ₹19.83 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹18.03 | ₹16.23 - ₹19.83 | +200.0% | EPS: ₹2.56, BVPS: ₹22.29 |
SAMPRE Intrinsic Value vs Market Price — All Valuation Models
Sampre Nutritions fair value range ₹5–₹18 vs current market price ₹6.01 across 8 valuation models. For current market price and key ratios, visit Sampre Nutritions stock price NSE.
SAMPRE Intrinsic Value Analysis — Undervalued or Overvalued?
Sampre Nutritions median intrinsic value ₹16.38, current price ₹6.01 — Trading Below Calculated Value by 172.5%, margin of safety 63.3%.
What is the intrinsic value of SAMPRE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sampre Nutritions (SAMPRE) is ₹16.38 (median value). With the current market price of ₹6.01, this represents a +172.5% variance from our estimated fair value.
The valuation range spans from ₹5.00 to ₹18.03, indicating ₹5.00 - ₹18.03.
Is SAMPRE undervalued or overvalued?
Based on our multi-method analysis, Sampre Nutritions (SAMPRE) appears to be trading below calculated value by approximately 172.5%.
SAMPRE Financial Health — Key Ratios vs Industry Benchmarks
Sampre Nutritions financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.77 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 3.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.48x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
SAMPRE Cash Flow Quality — Operating & Free Cash Flow
Sampre Nutritions operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-1 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹0 Cr | ₹-38 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |